Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Veracyte ( NASDAQ:VCYT ) Third Quarter 2022 Results Key Financial Results Revenue: US$75.6m (up 25% from 3Q 2021). Net...
Veracyte (VCYT) delivered earnings and revenue surprises of 50% and 12.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SOUTH SAN FRANCISCO, Calif., November 02, 2022--Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the third quarter ended September 30, 2022.
SOUTH SAN FRANCISCO, Calif., November 01, 2022--Veracyte Announces Three Abstracts to Be Presented at SITC 2022 Annual Meeting
SOUTH SAN FRANCISCO, Calif., October 27, 2022--Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in a fireside chat at the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, at 1:25 p.m. Eastern Time.
SOUTH SAN FRANCISCO, Calif., October 25, 2022--New data suggest Decipher GRID-derived genomic signature can help identify men with prostate cancer who should receive high-dose radiotherapy
SOUTH SAN FRANCISCO, Calif., October 24, 2022--Veracyte Data Presented at ATA Annual Meeting Provide New Insights into Molecular Underpinnings of Thyroid Cancer
SOUTH SAN FRANCISCO, Calif., October 18, 2022--Veracyte, Inc. (Nasdaq: VCYT) today announced that two abstracts highlighting the clinical value of the company’s Envisia Genomic Classifier and Percepta Nasal Swab tests in interstitial lung disease (ILD) and lung cancer, respectively, were presented as posters today at the American College of Chest Physicians (CHEST) Annual Meeting 2022, taking place in Nashville, Tenn., October 16-19.
Some Veracyte, Inc. ( NASDAQ:VCYT ) shareholders are probably rather concerned to see the share price fall 36% over the...
SOUTH SAN FRANCISCO, Calif., October 13, 2022--Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the third quarter of 2022 after the close of market on Wednesday, November 2, 2022. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.